Article info
PDFClinical and epidemiological research
Extended report
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
- Correspondence to Dr Kevin L Winthrop, Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA; Winthrop{at}ohsu.edu
Citation
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
Publication history
- Received December 19, 2014
- Revised January 29, 2015
- Accepted February 1, 2015
- First published March 20, 2015.
Online issue publication
April 18, 2023
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/